chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Anaemia, Blood test, Haemoglobin decreased, Heavy menstrual bleeding, Peripheral swelling
Clinical narrative: Extremely heavy menstrual bleeding for 27 days  with large clots which resulted in anemia.  Swelling of feet
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Red blood cell count decreased, Thrombosis
Clinical narrative: Extremely heavy menstrual bleeding for 27 days  with large clots which resulted in anemia.  Swelling of feet
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash, Urticaria
Clinical narrative: Itchy skin,  hives, redness and welts on back of my head, Rash on my forearms, chest, stomach, back, neck and legs
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Impaired work ability, Palpitations, Vomiting
Clinical narrative: Threw up all the way home. Heart racing uncontrollably. Severely sick for 10 days still recovering - by far worse than any flu. The event has resulted in a working disability hopefully temporarily.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: no adverse event; but a booster vaccine was administered by nurse to a child aged 12yo
Age: 38.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Mechanical urticaria, Oesophageal discomfort, Pruritus
Clinical narrative: Extreme itchiness accompanied with dermatographia on most of my body.  Additionally light tightness in asophagus
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Erythema, Fatigue, Myalgia, Pain in extremity
Clinical narrative: Sore arm starting fee hours after, waking me through night. ?Covid arm? next morning noticed. Red, swollen, itchy, raised. Achy muscles. Slight fatigue. Tylenol and Advil taken, ice pack to arm.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pruritus, Sleep disorder, Vaccination complication
Clinical narrative: Sore arm starting fee hours after, waking me through night. ?Covid arm? next morning noticed. Red, swollen, itchy, raised. Achy muscles. Slight fatigue. Tylenol and Advil taken, ice pack to arm.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, COVID-19, COVID-19 pneumonia, Cardiac failure acute, Left ventricular failure
Clinical narrative: Patient received Pfizer COVID vaccine on 7/9/21 and 7/30/21. On 12/29/21, patient admitted to our facility for acute on chronic diastolic CHF, AKI, and pneumonia due to COVID-19 virus. On 12/31/21, patient was discharged home and during hospitalization, patient remained on room air and did not require dexamethasone therapy.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient received Pfizer COVID vaccine on 7/9/21 and 7/30/21. On 12/29/21, patient admitted to our facility for acute on chronic diastolic CHF, AKI, and pneumonia due to COVID-19 virus. On 12/31/21, patient was discharged home and during hospitalization, patient remained on room air and did not require dexamethasone therapy.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Crying, Ear pain, Sleep deficit, Tinnitus
Clinical narrative: Developed tinnitus ringing in both ears which I never had.  Then when I got COVID, the virus immediately attacked my left ear with sharp pains in the ear enough to make me bellow out.  The tinnitus is causing me sleep deprivation.  I have scheduled a hearing appointment with an audiologist.  This is no joke.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling
Clinical narrative: Left arm Swollen from shoulder to elbow twice the size as normal. Benadryl & ice & antibiotic
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Nasal congestion, Pain, Pyrexia
Clinical narrative: High fever of 101+ for 2 days, low fever for an additional 2 days, severe nasal congestion, persistent cough for one week, moderate to severe aches
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Diabetes mellitus inadequate control, SARS-CoV-2 test positive
Clinical narrative: Patient received Moderna COVID vaccine on 2/27/21 (lot # 002A21A), 3/27/21 (lot # 026B21A), and 10/30/21 (lot # 014F21A).  On 12/28/21, patient tested positive for COVID. On 12/29/21, patient admitted to our facility med/surg unit for acute hypoxemic respiratory failure and pneumonia due to COVID-19 and uncontrolled diabetes type 2.  Patient was provided with remdesivir for 4 days. On 1/2/22, patient decided to leave the hospital AMA (against medical advice) after a thorough discussion of risks of leaving the hospital.  He declined oxygen therapy at discharge. He was sent a prescription to complete his course of Dexamethasone in an attempt to improve his tenuous respiratory status (the risks of worsening respiratory decompensation are greater at this time to his life than elevated glucose that may result from steroid use).
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Facial pain, Night sweats, Pyrexia, Vision blurred
Clinical narrative: fever, blurred vision, night sweats, joint pain, severe facial pain.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose increased, Cold sweat, Drooling, Eye movement disorder, Syncope
Clinical narrative: Patient was taken to bathroom, by caregiver of the board and care unit, after completing 15-minute recovery, post Pfizer COVID-19 booster shot. Patient did not have any complaints or symptoms, during the 15-minute recovery period. Per caregiver, after patient had large bowel movement, patient?s? eyes began rolling and she was drooling?. Caregiver called out for help. Upon arrival, health vaccination team nurses called out to patient, and patient made eye contact and was able to state full name. Patient?s skin was cool and clammy, BP = 85/53, P=55, R=16, O2 Sat= 98%, on 2L NC. Patient placed on mat on floor, alert and oriented to person and place. 911 called. Paramedics arrived at 1525 and took over care of patient. BP= 130/76, P= 64, R=18, O2 Sat=100 % on 2L NC, Blood Glucose Level = 174. Per paramedics, patient to be transported to hospital via ambulance. Patient transported at 1539 and was alert and talking during transfer. Per caregivers at board and care, patient had vasovagal/syncopal episode while in the shower, approximately 2 weeks ago
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Epistaxis, Hunger, Malaise, Paraesthesia
Clinical narrative: Blood pressure spike, nose bled, before and after malaise, strong hunger, tingling and coldness in arms and legs (last part occurred two days in a row).
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral coldness
Clinical narrative: Blood pressure spike, nose bled, before and after malaise, strong hunger, tingling and coldness in arms and legs (last part occurred two days in a row).
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Peripheral swelling, Rash, Swelling
Clinical narrative: Arm swollen again rash, arm pit & side swollen, pain
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Inflammation, Ocular discomfort, Ocular hyperaemia, Photophobia
Clinical narrative: Flare up of acute uveitis in left eye only. Redness, discomfort, sensitivity to light. First flare up in 6 months. First noticed two mornings (42+ hours after day of vaccine dose. First day after dose included general body inflammation, which I suspected might trigger uveitis, now knowing my HLA B-27.  Currently self-treating with leftover Durezol steroid drops from my previous case. I am now realizing that while that previous case came before my first dose in the Pfizer vaccine series (May 2021), my uveitis symptoms did persist for 2-3 weeks after that first vaccine dose, which may have prolonged the inflammation. No signs of uveitis during my second Pfizer dose in June 2021. Current uveitis case still ongoing.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Uveitis
Clinical narrative: Flare up of acute uveitis in left eye only. Redness, discomfort, sensitivity to light. First flare up in 6 months. First noticed two mornings (42+ hours after day of vaccine dose. First day after dose included general body inflammation, which I suspected might trigger uveitis, now knowing my HLA B-27.  Currently self-treating with leftover Durezol steroid drops from my previous case. I am now realizing that while that previous case came before my first dose in the Pfizer vaccine series (May 2021), my uveitis symptoms did persist for 2-3 weeks after that first vaccine dose, which may have prolonged the inflammation. No signs of uveitis during my second Pfizer dose in June 2021. Current uveitis case still ongoing.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient was given the 12+ dose (30mcg/0.3ml) dose of Pfizer 01/04/2022 at 12:30pm.  He is currently only 11 years old and does not turn 12 until 02/01/2022. Mother was notifed at 7pm 1/04/22 when discovered. No known current adverse events
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: The resident was scheduled to receive a third dose at a clinic on 9/15/21. Patient went to pharmacy just prior and got the dose and it was not reported - causing the patient to get a duplication of the 3rd dose. Pt also had 2 covid cards.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site inflammation, Urticaria
Clinical narrative: Pt developed inflammation and 5 inch welt on 12/16 at the injection site. Pt went to Dr. on 12/17 and was prescribed doxycycline. Pt educated on possible injection site reactions with Covid-19 vaccines.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Heart rate increased
Clinical narrative: Heart rate increased rapidly with chest tightness and some shortness of breath. Symptoms lasted from 7:52 PM 12/17/2021 to around 10:00 AM 12/18/2021.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Hypoxia
Clinical narrative: Narrative:  Patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 78 but did not have frequent medical contact through the system. He had pulmonary fibrosis with severe hypoxemia that required 5 L of oxygen. Other disease states of HLD, HTN, and anemia appeared to be under control per note from 3/25/20.
Age: 99.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse drug reaction, Asthenia, COVID-19, Death, Fall
Clinical narrative: Narrative:  Patient previously tested Covid positive on 12/9/20 and was admitted through 12/31/20. He did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 97 and had to be readmitted on 1/10/21 after a fall and feeling weak. PMH included CAD, dementia, AAA, prostate cancer, and thrombocytopenia.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pain, Peripheral swelling, Sinus congestion
Clinical narrative: Narrative: Pt reported bilateral leg swelling after covid vaccine dose #1 given.  Pt went to private sector ER for evaluation and blood clot was ruled out. Next day swelling improved. On 4/19/21 pt complaint of sever pain behind eye possibly  related to the covd vaccine, however pt had called his primary care provider  with complaint of sinus congestion on 4/14/21 for past 3 days concerned it was a sinus infection, Nurse recommended pt to go ER for eye pain evaluation. Pt mentioned leg swelling but reported this as chronic issue. Likely  neither event vaccine related but reported since possible.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram normal, Differential white blood cell count normal, Full blood count normal, Headache, Magnetic resonance imaging normal
Clinical narrative: Narrative: Patient reported colored horizontal line of lateral peripheral vision both eyes on 4/16/21 in afternoon (lasted about 10 min) then blurry vision for approximately 10 min (resolved by the time seen in ER 4/16/21 approx. 2:30am - per RN note from hospital). After blurry vision global headache reported. Pt with history of migraine headache, wears glasses, denied nausea and vomiting. CBC w/ diff, Ct, MRI, MRV unremarkable. Pt discharged from ER within 24 hours. Received ibuprofen 600mg.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Venogram normal, Vision blurred, Visual field defect
Clinical narrative: Narrative: Patient reported colored horizontal line of lateral peripheral vision both eyes on 4/16/21 in afternoon (lasted about 10 min) then blurry vision for approximately 10 min (resolved by the time seen in ER 4/16/21 approx. 2:30am - per RN note from hospital). After blurry vision global headache reported. Pt with history of migraine headache, wears glasses, denied nausea and vomiting. CBC w/ diff, Ct, MRI, MRV unremarkable. Pt discharged from ER within 24 hours. Received ibuprofen 600mg.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse drug reaction, Cardio-respiratory arrest, Death, Dyspnoea, Malaise
Clinical narrative: Narrative:  Patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was admitted to Hospital and coded twice before passing away on 3/11/21. Daughter reports that patient began not feeling well and having difficulty breath shortly after receiving his second Pfizer COVID-19 vaccine on 2/26/21. Death occurred at outside facility and suspected cause of death not apparent. Patient was 78 and PMH included chronic hypoxemic respiratory failure, HTN, T2DM, COPD.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Exposure to SARS-CoV-2, Headache, Myalgia
Clinical narrative: Patient tested COVID positive following completion of COVID vaccine series. 02/03 COVID vaccine dose #1 02/24 COVID vaccine does #2 04/12 COVID tested due to exposure to someone with COVID, tested COVID positive, no symptoms 04/13 reports intermittent cough, runny nose, intermittent headache 04/14 reports congestion, runny nose, myalgia 04/15 reports congestion, ongoing will treat with otc meds 04/17 reports cough is nearly resolved, denies fatigue or SOP 04/18 asymptomatic.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Patient tested COVID positive following completion of COVID vaccine series. 02/03 COVID vaccine dose #1 02/24 COVID vaccine does #2 04/12 COVID tested due to exposure to someone with COVID, tested COVID positive, no symptoms 04/13 reports intermittent cough, runny nose, intermittent headache 04/14 reports congestion, runny nose, myalgia 04/15 reports congestion, ongoing will treat with otc meds 04/17 reports cough is nearly resolved, denies fatigue or SOP 04/18 asymptomatic.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Brain natriuretic peptide increased, Computerised tomogram thorax abnormal, Dizziness, Dyspnoea
Clinical narrative: Narrative: 73-year-old M with history of hyperlipidemia and T2DM who presents with two days of palpitations, SOB, tachycardia, and dizziness. Patient reports palpitations and a sensation of heart racing that began 12 hours into his drive back from trip. On arrival home patient continued to have palpitations while ambulating and intermittently felt lightheaded and dizzy, although denies ever losing consciousness. Denies any lower extremity pain or swelling. He denies any personal or family history of PEs. No recent illness or procedures. No personal history of malignancy, although per PCP note patient has never had colonoscopy. On arrival to the ED, patient was afebrile, HR initially 127 although decreased to 80s within several minutes without intervention, BP 140s/80s, RR 12-15, maintaining O2 sats on room air. Labs were significant for D-dimer 17.19, troponin 0.03, BNP 2708. CT PE revealed bilateral segmental and subsegmental PEs with evidence of right heart strain and patient was started on a heparin gtt and admitted to MICU for further management.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer, Heart rate decreased, Intensive care, Palpitations, Right ventricular dysfunction
Clinical narrative: Narrative: 73-year-old M with history of hyperlipidemia and T2DM who presents with two days of palpitations, SOB, tachycardia, and dizziness. Patient reports palpitations and a sensation of heart racing that began 12 hours into his drive back from trip. On arrival home patient continued to have palpitations while ambulating and intermittently felt lightheaded and dizzy, although denies ever losing consciousness. Denies any lower extremity pain or swelling. He denies any personal or family history of PEs. No recent illness or procedures. No personal history of malignancy, although per PCP note patient has never had colonoscopy. On arrival to the ED, patient was afebrile, HR initially 127 although decreased to 80s within several minutes without intervention, BP 140s/80s, RR 12-15, maintaining O2 sats on room air. Labs were significant for D-dimer 17.19, troponin 0.03, BNP 2708. CT PE revealed bilateral segmental and subsegmental PEs with evidence of right heart strain and patient was started on a heparin gtt and admitted to MICU for further management.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Tachycardia, Troponin
Clinical narrative: Narrative: 73-year-old M with history of hyperlipidemia and T2DM who presents with two days of palpitations, SOB, tachycardia, and dizziness. Patient reports palpitations and a sensation of heart racing that began 12 hours into his drive back from trip. On arrival home patient continued to have palpitations while ambulating and intermittently felt lightheaded and dizzy, although denies ever losing consciousness. Denies any lower extremity pain or swelling. He denies any personal or family history of PEs. No recent illness or procedures. No personal history of malignancy, although per PCP note patient has never had colonoscopy. On arrival to the ED, patient was afebrile, HR initially 127 although decreased to 80s within several minutes without intervention, BP 140s/80s, RR 12-15, maintaining O2 sats on room air. Labs were significant for D-dimer 17.19, troponin 0.03, BNP 2708. CT PE revealed bilateral segmental and subsegmental PEs with evidence of right heart strain and patient was started on a heparin gtt and admitted to MICU for further management.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Bedridden, Death, Dysphagia, Dyspnoea, Hypophagia
Clinical narrative: Narrative:  Patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was admitted to Hospital on 3/11/21 with dyspnea. He was transferred from a rehab facility as he could no longer care for himself due to being bed-bound. He lost 27 pounds over last 6 months due to progressive dysphagia limiting PO intake. PMH significant for dementia, CAD, HTN, COPD.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Weight decreased
Clinical narrative: Narrative:  Patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was admitted to Hospital on 3/11/21 with dyspnea. He was transferred from a rehab facility as he could no longer care for himself due to being bed-bound. He lost 27 pounds over last 6 months due to progressive dysphagia limiting PO intake. PMH significant for dementia, CAD, HTN, COPD.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Nasopharyngitis, Respiratory tract congestion, Rhinorrhoea
Clinical narrative: Narrative: Patient tested positive for COVID following completion of Covid vaccine series. 01/12 COVID vaccine dose #1 02/03 COVID vaccine dose #2 04/13 symptoms described as " summer cold, " runny nose, congestion, cough, Covid test positive 04/14 runny nose, new onset cough x1 week, 04/16 feeling much better.
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: Patient tested positive for COVID following completion of Covid vaccine series. 01/12 COVID vaccine dose #1 02/03 COVID vaccine dose #2 04/13 symptoms described as " summer cold, " runny nose, congestion, cough, Covid test positive 04/14 runny nose, new onset cough x1 week, 04/16 feeling much better.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Adverse drug reaction, Bedridden, Disorientation, Fall
Clinical narrative: Narrative:  Patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 87 and had a hospital stay from 2/18/21-2/24/21 for an NSTEMI and 2 broken ribs from 3 falls in the prior week. After hospitalization he was bedridden, disoriented and hallucinating. Comorbidities include CAD, CHF, HTN, and carotid artery stenosis.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Hallucination, Rib fracture
Clinical narrative: Narrative:  Patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 87 and had a hospital stay from 2/18/21-2/24/21 for an NSTEMI and 2 broken ribs from 3 falls in the prior week. After hospitalization he was bedridden, disoriented and hallucinating. Comorbidities include CAD, CHF, HTN, and carotid artery stenosis.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac arrest, Chest pain, Death
Clinical narrative: Narrative:  Patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient presented to MC on 3/8/21 with chest pain and suffered cardiac arrest. Patient had history of homelessness and substance abuse along with COPD.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Abnormal behaviour, Adverse drug reaction, Cognitive disorder, Death, Malnutrition
Clinical narrative: Narrative:  Patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 82 and the cause of death listed was vascular dementia. His cognitive status was declining up until his death along with his behavior. Caregiver had difficulty caring for patient and hospice was discussed prior to his passing. Patient was malnourished and had COPD.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Vascular dementia
Clinical narrative: Narrative:  Patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 82 and the cause of death listed was vascular dementia. His cognitive status was declining up until his death along with his behavior. Caregiver had difficulty caring for patient and hospice was discussed prior to his passing. Patient was malnourished and had COPD.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse drug reaction, Death
Clinical narrative: Narrative: Patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Details surrounding his death are not clear. He was 89 with CDK stage 4 and was obese. He died at home surrounded by his family.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Bladder cancer, Chronic kidney disease, Coronary artery disease, Death, Diabetes mellitus
Clinical narrative: Narrative:  Patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. The listed cause of death was CAD. Patient also had DM, CKD, and bladder cancer along with morbid obesity.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Obesity
Clinical narrative: Narrative:  Patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. The listed cause of death was CAD. Patient also had DM, CKD, and bladder cancer along with morbid obesity.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Hyperhidrosis, Nausea
Clinical narrative: Narrative: 04/19/2021 ADDENDUM STATUS: COMPLETED S/0: ON 4/16 AT 15:17 WHILE PATIENT WAS IN THE MONITORING AREA, HE BECAME DIAPHORETIC WITH DIZZINESS AND NAUSE. HE IS ALERT AND ORIENTED X3, ABLE TO TALK DURING OBSERVATION. PATIENT WORKS NIGHTS AND ONY GOT ABOUT 3 HOUR SLEEP PRIOR TO VACCINATION, PATIENT ALSO FASTING FOR RELIGIOUS REASONS. PATIENT LAID DOWN ON STRETCHER AND VS TAKEN AS FOLLOWS" 15:17 BP: 115/75 HR 66 02 SAT 97% 15:23 BP: 131/92 HR 75 O2 SAT 97% FACIAL COLOR IMPROVED 15:28 BP 130/92 HR 66 O2 ST 98% TREATMENT: OBSERVATION, ICE PACK AND JUICE. A PATIENT IMPROVING IN VS AFTER ADMINSTRATION OF ICE PACK AND JUICE. PATIENT REPORTED HIS NAUSA AND DIZZINESS RESOLVED AND HE WAS FEELING BETTER. NO DIZZINESS. PATIENT ADVISED TO SEEK ADDITIONAL MEDICAL CARE IF HE WERE TO HAVE SIMILAR SYMPTOMS OR WORSENING SIDE EFFECTS. RN SIGNED: 04/19/2021 16:38
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Pt received first Moderna COVID vaccine 3/21/21 through the clinic. Clinic was notified on 4/15 that the patient had passed away at home on 4/7/21 - this death has not been verified and additional details of death have not been provided. Was pt previously covid positive? No Are there any predisposing factors (i.e. PMH, HPI, allergy history etc) for patient experiencing adverse drug event? Yes - chronic comorbidities placing at an increased risk of death Any occurrence of an ADR at time of administration or during time of observation? No Did patient recover from event? N/A, died Was there an ADR between observation period and date of death? No Was patient hospitalized prior to vaccination? No Was patient hospitalized between vaccination and date of death? No Was patient hospitalized prior to death No What are the possible cause of death? unclear, passed at home with no further details.
Age: 96.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse drug reaction, Chest tube insertion, Death, Weight decreased
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 94 and contributing comorbidities include sarcoidosis, afib, nonischemic congestive cardiomyopathy w/ ICD, DM2, HTN, HLN, Dementia/ senile. Patient required hospice care on 2/19/21 and had lost significant weight up to that point and had a chest tube in place.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Details surrounding death on 3/17/21 not known. Pulmonary Note dated 2/17/21 detailed condition getting worse w/ increasing shortness of breath. He had a 40 PPY smoking history with interstitial lung disease, HTN, ITP, PVD. He required 3 L of oxygen.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was discharged from hospital around 2/16/21 where he was evaluated for chest pain. He had paroxysmal afib and wide complex tachycardia. Other comorbidities include CAD w/ CABG, HTN, HLD. No mention in chart of circumstances surrounding death. Patient was 77.
Age: 99.0
Sex: M
Vaccine: COVID19
Symptoms: Cervical vertebral fracture, Death, Deep vein thrombosis, Fall
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 97 and receiving hospice care on 2/21/21. He was previously admitted on 1/29/21 to hospital for a fall resulting in a dens fracture and eventually suffered from a DVT. He passed away on 2/23/21. Comorbidities include advanced age, CKD, coronary arteriosclerosis, sleep apnea, and cognitive decline.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Fall, Spinal decompression, Spinal operation
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Comorbidities include CKD, anemia, DM2, CAD, HTN, HLD. On 2/19/21 it was reported that patient spent some time in the hospital over the last week after suffering several falls while a resident in a nursing home. He underwent back surgery for spinal decompression on 3/2/21 . He passed away at the hospital on 3/31/21 with unknown cause of death. Patient also had CHF, COPD, Crohns Disease, anxiety/depression.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Hyperhidrosis
Clinical narrative: Narrative: Patient presented to covid vaccine clinic for his first of 2 vaccinations. Received first show then next day: Patient called the nurse clinical call center reporting dizziness and sweating . Patient presented to ED with chills,sweating and dizzieness. Symptoms did resolve.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Death, Type 2 diabetes mellitus
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Comorbidities include diabetes, HLD, HTN, aortic stenosis, kidney stones, smoking. He was found deceased in his bed on 4/2/21 with unknown cause of death. Medical examiner listed possible causes of death as 1. Natural causes 2. possible due to hypertensive heart disease 3. Probable diabetes mellitus 2
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: NARRATIVE:
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal distension, Condition aggravated, Death, Disease progression, Haematoma muscle
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was inpatient when receiving his second COVID-19 dose on 2/9/2021. Patient was admitted on 2/4/21 with acute encephalopathy, respiratory failure, and septic shock after being transferred from MICU. Hospital course included a internal jugular thrombus and a hematoma formation in his muscle. Plan was to be discharged to short term rehab but patient was uncooperative and left on 2/19/21 against medical advice. Patient readmitted on 3/13/21 with swelling in his legs and abdomen primarily as a result of his progressing hepatic encephalopathy from his liver cancer. Patient transitioned to hospice were he deceased on 3/25/21. Patient's comorbidities include metastatic inoperable multifocal hepatocellular carcinoma, cirrhosis in setting of Hepatitis C, lymphoma, polysubstance abuse, COPD.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Hepatic cancer, Hepatic encephalopathy, Jugular vein thrombosis, Patient uncooperative, Peripheral swelling
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was inpatient when receiving his second COVID-19 dose on 2/9/2021. Patient was admitted on 2/4/21 with acute encephalopathy, respiratory failure, and septic shock after being transferred from MICU. Hospital course included a internal jugular thrombus and a hematoma formation in his muscle. Plan was to be discharged to short term rehab but patient was uncooperative and left on 2/19/21 against medical advice. Patient readmitted on 3/13/21 with swelling in his legs and abdomen primarily as a result of his progressing hepatic encephalopathy from his liver cancer. Patient transitioned to hospice were he deceased on 3/25/21. Patient's comorbidities include metastatic inoperable multifocal hepatocellular carcinoma, cirrhosis in setting of Hepatitis C, lymphoma, polysubstance abuse, COPD.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Dehydration, Dysstasia, Muscular weakness
Clinical narrative: Narrative: Patient is a 75-year-old male, was scheduled for his first COVID-19 vaccine on 2/6/21 at 10:45 AM. He received the MOderna vaccine (lot: 013M20A) in the right deltoid muscle. The patient remained in the facility for 15 minutes post-vaccine administration. On 2/7/21, the patient visited the Hospital with complaints of lower extremity weakness (unable to stand) and dehydration. After receiving IV fluids and a complete work-up, the patient was discharged. The patient reported that the symptoms subsided the next day. He cancelled his second COVID-19 appointment at this tie. A neurology visit on 3/15/21 ruled out other disease states such as Guillain Barre Syndrome. On 3/18/21, the patient agreed to schedule his second COVID-19 vaccine in the community. It is unknown if the patient followed through with this request.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Foot amputation, Infection, Surgery
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. On 2/3/21, notes state patient was inpatient at hospital after having multiple surgeries/partial amputation of left foot after receiving an infection. Patient not receiving care from our hospital so unclear if passing on 2/28/21 was related to infection/complications from surgery. Comorbidities include advanced age, CKD, prostate cancer, DM2, CAD, HTN, HLD.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative: Required transfer to Emergency Department for observation. Patient was given a 1 L bolus of normal saline.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Narrative: Patient is a 73 year old MALE who received the 1st dose of COVID vaccine 3/3/21. Spoke w/pt today RE: adverse reaction related to the vaccination.-------------------------------------------------------------------------SYMPTOMS: Fever No if yes temp: n/a Fatigue Yes Myalgia No Arthralgia No Rash/Hives No SOB no Bell's Palsy No Injection Site Reaction No Other No If yes describe: felt tired x2 days
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Injection site pruritus
Clinical narrative: Narrative:  Patient is a 72 year old MALE who received the 1st dose of COVID vaccine 3/3/21. Spoke w/pt today RE: adverse reaction related to the vaccination. ---------------------------------------------------- ----------- SYMPTOMS: Fever No If yes temp: n/a Fatigue No Myalgia No Arthralgia No Rash/Hives No SOB No Bell's Palsy No Injection Site Reaction Yes Other No If yes describe: itching at injection site x1-2 days
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site discomfort
Clinical narrative: Narrative: Patient is a 80 year old MALE who received the 1st dose of COVID vaccine 3/3/21. Spoke w/pt today RE: adverse reaction related to the vaccination. ------------------------------------------------------- ----------------SYMPTOMS: Fever No if yes temp: n/a Fatigue No Myalgia No Arthralgia No Rash/Hives No SOB No Bell's Palsy No Injection Site Reaction Yes Other No If yes describe: arm discomfort x1 day
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure, Death, Fluid retention, General physical health deterioration, Multiple organ dysfunction syndrome
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 87 and patient was in rehab in Feb 2021 in slow multi organ failure requesting d/c to hospice. Patient was in hospice 2/13-2/19 for severe heart failure resulting in 40 pound fluid weight gain since November 2020 before returning to ER on 2/19/21 after wishes to restart aggressive life sustaining treatment vs. palliative approach. He was stabilized and discharged home on 3/3/21. Patient was readmitted on 3/16/21 after his condition continued declining at home. His heart and kidney failure progressed while inpatient until he passed away on 3/20.21. His Comorbidities include chronic afib on apixaban, severe mitral regurgitation, aortic stenosis, AAA, OSA, CKD, HTN, CHF.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Renal failure, Weight increased
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 87 and patient was in rehab in Feb 2021 in slow multi organ failure requesting d/c to hospice. Patient was in hospice 2/13-2/19 for severe heart failure resulting in 40 pound fluid weight gain since November 2020 before returning to ER on 2/19/21 after wishes to restart aggressive life sustaining treatment vs. palliative approach. He was stabilized and discharged home on 3/3/21. Patient was readmitted on 3/16/21 after his condition continued declining at home. His heart and kidney failure progressed while inpatient until he passed away on 3/20.21. His Comorbidities include chronic afib on apixaban, severe mitral regurgitation, aortic stenosis, AAA, OSA, CKD, HTN, CHF.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Narrative: Patient is a 69 year old MALE who received the 1st dose of COVID vaccine 3/3/21. Spoke w/pt today RE: adverse reaction related to the the vaccination.------------------------------------------------------------------ SYMPTOMS: Fever No If yes temp: n/a Fatigue No Myalgia No Arthralgia No Rash/Hives No SOB No Bell's Palsy No Injection Site Reaction Yes Other No if yes describe: arm soreness x2 days
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Pt has PMH significant for Multiple Myeloma, Chronic Kidney Disease, Hypertension, and Hyperlipidemia. No information regarding patient death.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood glucose decreased, COVID-19, COVID-19 pneumonia, Decreased appetite
Clinical narrative: Narrative:  COVID POSITIVE after completion of COVID VACCINE series 05/05 Pt seen in ED, reported bleeding from his mouth, BS less than 45 (took 12 units of insulin lispro but didn't eat) in ED, reports feeling dizzy, reports being weaker and sleepier in the past week with decreased appetite; dx'd with COVID pneumonia with hemoptysis; admitted to hospital 05/10 discharged from hospital 05/11 still c/o productive cough, body aches alleviated with apap, working from home, continued diarrhea
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Haemoptysis, Insulin therapy, Mouth haemorrhage
Clinical narrative: Narrative:  COVID POSITIVE after completion of COVID VACCINE series 05/05 Pt seen in ED, reported bleeding from his mouth, BS less than 45 (took 12 units of insulin lispro but didn't eat) in ED, reports feeling dizzy, reports being weaker and sleepier in the past week with decreased appetite; dx'd with COVID pneumonia with hemoptysis; admitted to hospital 05/10 discharged from hospital 05/11 still c/o productive cough, body aches alleviated with apap, working from home, continued diarrhea
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Productive cough, SARS-CoV-2 test positive, Somnolence
Clinical narrative: Narrative:  COVID POSITIVE after completion of COVID VACCINE series 05/05 Pt seen in ED, reported bleeding from his mouth, BS less than 45 (took 12 units of insulin lispro but didn't eat) in ED, reports feeling dizzy, reports being weaker and sleepier in the past week with decreased appetite; dx'd with COVID pneumonia with hemoptysis; admitted to hospital 05/10 discharged from hospital 05/11 still c/o productive cough, body aches alleviated with apap, working from home, continued diarrhea
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Nausea
Clinical narrative: Narrative: She reports having developed mild nausea that started about 6-8 hours after the first vaccination, which lasted for about 24 hours. She was able to eat and drink during that time and did not experience any diarrhea, vomiting, or abdominal cramping. Only other reported adverse effect was tenderness to the injection site that lasted about 1.5 days (not associated with rash or erythema).
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Bradykinesia, COVID-19, COVID-19 pneumonia, Cough
Clinical narrative: Narrative:  05/03 Pt's wife reports pt is very sleepy, tired, low energy, SOB most of the time, no appetite, "head not right," dragging, slow on things, severe dry coughing x 2 weeks, wakes up every night due to cough 05/05 Seen by PCP, referred to ED due to looking volume depleted and continued c/o as above, admitted with covid pneumonia, hypoxemia 05/10 discharged from hospital, received remdesivir x 5 days, discharged on steroids and supplemental oxygen
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Dyspnoea, Fatigue, Feeling abnormal, Hypovolaemia
Clinical narrative: Narrative:  05/03 Pt's wife reports pt is very sleepy, tired, low energy, SOB most of the time, no appetite, "head not right," dragging, slow on things, severe dry coughing x 2 weeks, wakes up every night due to cough 05/05 Seen by PCP, referred to ED due to looking volume depleted and continued c/o as above, admitted with covid pneumonia, hypoxemia 05/10 discharged from hospital, received remdesivir x 5 days, discharged on steroids and supplemental oxygen
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, SARS-CoV-2 test positive, Sleep disorder, Somnolence
Clinical narrative: Narrative:  05/03 Pt's wife reports pt is very sleepy, tired, low energy, SOB most of the time, no appetite, "head not right," dragging, slow on things, severe dry coughing x 2 weeks, wakes up every night due to cough 05/05 Seen by PCP, referred to ED due to looking volume depleted and continued c/o as above, admitted with covid pneumonia, hypoxemia 05/10 discharged from hospital, received remdesivir x 5 days, discharged on steroids and supplemental oxygen
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Joint range of motion decreased, Product administered at inappropriate site, Tendonitis
Clinical narrative: Narrative: post vaccine, L shoulder has progressively been more painful. Limited range of motion consistent with tendinitis. Suspect placement vaccine an issue
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Headache
Clinical narrative: Narrative: He developed a headache and fatigue about 3-4 hours post-vaccination, which persisted for 2-3 days afterwards. On the 2nd day, he started to take OTC acetaminophen, which assisted with headache, but the issues did not completely resolve until day 3 and did not feel back to baseline until day 6.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Muscular weakness
Clinical narrative: Narrative: Patient is a 63-year-old female, she reports a history of significant spinal stenosis. She states from time to time her legs just feel wobbly and give out on her. She was in the cafeteria, actually bought her lunch and felt like her legs got weak. She tried to sit down and missed the chair. Although she endorses some lightheadedness, there was no history of syncope, and she was brought to the ER from the canteen. She does report some lightheadedness, which she attributes to not having eaten anything today yet, she also received her second coronavirus vaccination with Moderna vaccine about an hour ago. She denies any traumatic complaints, no headache or fever, no chest pain, cough or shortness of breath. She denies palpitations, abdominal pain, vomiting or diarrhea. She does endorse chronic back pain, which is unchanged. After observation she was sent home